Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
42.14 USD | +0.56% | +0.02% | -0.59% |
Apr. 18 | Sector Update: Health Care Stocks Mixed Pre-Bell Thursday | MT |
Apr. 18 | Cerevel Therapeutics' Potential Parkinson's Treatment Meets Primary Endpoint in Phase 3 Study | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.59% | 7.61B | |
-2.00% | 104B | |
+2.02% | 97.42B | |
+0.79% | 22.2B | |
-17.77% | 21.23B | |
-11.11% | 18.33B | |
-42.83% | 16.35B | |
-15.76% | 15.06B | |
+3.88% | 13.98B | |
+34.58% | 11.66B |
- Stock Market
- Equities
- CERE Stock
- News Cerevel Therapeutics Holdings, Inc.
- Cerevel Therapeutics : Morgan Stanley Starts Cerevel Therapeutics Holdings at Overweight With $27 Price Target